Squarepoint
FLNA

Squarepoint’s Filana Therapeutics FLNA Stock Holding History

Squarepoint’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,396
Closed -$39.7K – 4809
2025
Q3 		$36.1K Sell
12,396
-94,073
-88% -$216K ﹤0.01% 4256
2025
Q2 		$193K Buy
106,469
+41,345
+63% +$73.6K ﹤0.01% 3988
2025
Q1 		$97.7K Buy
65,124
+11,034
+20% +$27.8K ﹤0.01% 4227
2024
Q4 		$128K Buy
54,090
+43,757
+423% +$768K ﹤0.01% 4636
2024
Q3 		$304K Buy
+10,333
New +$238K ﹤0.01% 3435
2023
Q3 		– Sell
-32,755
Closed -$803K – 4187
2023
Q2 		$803K Buy
+32,755
New +$789K ﹤0.01% 2329
2022
Q4 		– Sell
-20,995
Closed -$878K – 3549
2022
Q3 		$878K Buy
+20,995
New +$567K ﹤0.01% 1851
2022
Q2 		– Sell
-14,139
Closed -$525K – 3307
2022
Q1 		$525K Buy
+14,139
New +$599K ﹤0.01% 1976
2021
Q4 		– Sell
-36,405
Closed -$2.26M – 3477
2021
Q3 		$2.26M Buy
36,405
+29,710
+444% +$2.48M 0.01% 1145
2021
Q2 		$572K Sell
6,695
-45,090
-87% -$2.42M ﹤0.01% 2032
2021
Q1 		$2.33M Sell
51,785
-46,960
-48% -$1.85M 0.01% 986
2020
Q4 		$673K Buy
+98,745
New +$882K 0.01% 1590
2020
Q3 		– Sell
-18,554
Closed -$57K – 2799
2020
Q2 		$57K Buy
+18,554
New +$84.2K ﹤0.01% 2087
2015
Q3 		– Sell
-5,886
Closed -$71K – 556
2015
Q2 		$71K Buy
+5,886
New +$80.6K 0.02% 415

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Squarepoint's FLNA Position: Q4 2025 in Review

Squarepoint sold out of Filana Therapeutics (FLNA) in Q4 2025, closing a stake of 12,396 shares — an estimated $39.7K sold.

Squarepoint first reported a position in FLNA in Q2 2015 and held it in 14 quarters. The position peaked at $2.33M in Q1 2021. 107 funds tracked by Wall St. Rank hold FLNA as of Q4 2025.

  • Squarepoint reported no remaining Filana Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Squarepoint sold 12,396 Filana Therapeutics shares in Q4 2025, an estimated $39.7K.
  • Squarepoint first reported a position in Filana Therapeutics in Q2 2015 and held it in 14 quarters.
  • Squarepoint's Filana Therapeutics position peaked at $2.33M in Q1 2021.
  • 107 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2025.

Based on Squarepoint's 13F filing for Q4 2025, filed 13 Feb 2026.